COVID-19 Vaccine Hesitancy Among Patients With Breast Cancer | Breast Cancer | JN Learning | AMA Ed Hub [Skip to Content]
[Skip to Content Landing]

Attitudes and Factors Associated With COVID-19 Vaccine Hesitancy Among Patients With Breast Cancer

Educational Objective
To identify the key insights or developments described in this article
1 Credit CME

The COVID-19 pandemic has had a substantial effect on cancer care.1 The recent widespread availability of vaccines against SARS-CoV-2 is a promising strategy to prevent COVID-19–associated mortality. However, previous reports have shown a high hesitancy rate to receive a COVID-19 vaccine among oncologic patients.2,3 Because breast cancer is the most commonly diagnosed malignant neoplasm,4 it is imperative to evaluate the specific concerns regarding COVID-19 vaccination among patients with this disease.

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

Article Information

Accepted for Publication: April 21, 2021.

Published Online: June 10, 2021. doi:10.1001/jamaoncol.2021.1962

Corresponding Author: Cynthia Villarreal-Garza, MD, DSc, Breast Cancer Center, Hospital Zambrano Hellion TecSalud, Tecnologico de Monterrey, Batallón de San Patricio 112, Real de San Agustín, 66278 San Pedro Garza García, Nuevo León, Mexico (cynthia.villarreal@tecsalud.mx).

Author Contributions: Dr Villarreal-Garza had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: All authors.

Acquisition, analysis, or interpretation of data: Villarreal-Garza, Vaca-Cartagena, Becerril-Gaitan, Ferrigno, Mesa-Chavez.

Drafting of the manuscript: Villarreal-Garza, Vaca-Cartagena, Becerril-Gaitan, Ferrigno, Mesa-Chavez.

Critical revision of the manuscript for important intellectual content: All authors.

Statistical analysis: Vaca-Cartagena, Becerril-Gaitan.

Administrative, technical, or material support: Villarreal-Garza, Alejandra Platas, Ana Platas.

Supervision: Villarreal-Garza, Mesa-Chavez.

Conflict of Interest Disclosures: Dr Villarreal-Garza reported grants from AstraZeneca and Roche; speaking honoraria from Roche, Myriad Genetics, Novartis, Pfizer, and Eli Lilly; travel fees from Roche, MSD Oncology, and Pfizer; and advisory roles at Roche, Novartis, Pfizer, and Eli Lilly. No other disclosures were reported.

Additional Contributions: We thank the organizations that helped to disseminate the survey: Médicos e Investigadores en la Lucha contra el Cáncer de Mama, Salvati AC, Coalición Mexicana por la Salud Mamaria, Cáncer Warriors de México, Red Contra el Cáncer, Programa de Supervivientes del Instituto Nacional de Cancerología, Pro Oncavi, Grupo Vida Plena Después Del Cáncer AC, Fundación Unidas Contigo, and Encauza.

References
1.
Jazieh  AR , Akbulut  H , Curigliano  G ,  et al; International Research Network on COVID-19 Impact on Cancer Care.  Impact of the COVID-19 pandemic on cancer care: a global collaborative study.   JCO Glob Oncol. 2020;6:1428-1438. doi:10.1200/GO.20.00351 PubMedGoogle Scholar
2.
Dutch Federation of Cancer Organizations. Kankerzorg in de anderhalvemeter-samenleving, wat is jouw ervaring? Accessed April 5, 2021. https://nfk.nl/nieuws/kankerzorg-in-de-anderhalvemeter-samenleving-wat-is-jouw-ervaring
3.
Barrière  J , Gal  J , Hoch  B ,  et al.  Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey.   Ann Oncol. 2021;32(5):673-674. doi:10.1016/j.annonc.2021.01.066 PubMedGoogle ScholarCrossref
4.
Sung  H , Ferlay  J , Siegel  RL ,  et al.  Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.   CA Cancer J Clin. Published online February 4, 2021. doi:10.3322/caac.21660PubMedGoogle Scholar
5.
Lazarus  JV , Ratzan  SC , Palayew  A ,  et al.  A global survey of potential acceptance of a COVID-19 vaccine.   Nat Med. 2021;27(2):225-228. doi:10.1038/s41591-020-1124-9 PubMedGoogle ScholarCrossref
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
Close
With a personal account, you can:
  • Track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
jn-learning_Modal_SaveSearch_NoAccess_Purchase
Close

Lookup An Activity

or

Close

My Saved Searches

You currently have no searches saved.

Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close